You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 3, 2026

Patent: 10,034,914


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,034,914
Title:Brain and neural treatments comprising peptides and other compositions
Abstract:The present invention generally relates to compositions and methods for treatment of subjects in need of muscle growth, muscle repair, improved muscular and neuromuscular control, and treatments for neuromuscular and neurological disorders, including brain disorders. In some cases, the composition may include nitric oxide and/or peptides such as thyrotropin-releasing hormone (TRH) and/or GnRH (gonadotropin-releasing hormone). The nitric oxide and/or peptides may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, or other structures containing nitric oxide and/or peptide. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin, e.g., onto a location where muscle growth, muscle repair, or improved muscular and neuromuscular control is desired, or on another suitable portion of the skin. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.
Inventor(s):Nicholas V. Perricone
Assignee: Transdermal Biotechnology Inc
Application Number:US15/460,527
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

A Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 10,034,914


Introduction

United States Patent 10,034,914 (hereafter "the ’914 patent") exemplifies technological innovation within its designated field, offering a detailed claim set that aims to secure intellectual property rights for advancing specific methodologies or compositions. An evaluation of the patent’s claims, their scope, and the broader patent landscape is essential for understanding its strategic value, potential vulnerabilities, and competitive positioning.

This analysis critically examines the core claims of the ’914 patent, assesses the scope and validity considerations, and maps the surrounding patent landscape to elucidate potential opportunities and risks for stakeholders.


Overview of the ’914 Patent

The ’914 patent was granted on July 24, 2018, with inventors and assignees that reflect the endeavor to protect innovations pertinent to a particular technology—presumably related to pharmaceutical compositions, biotechnology, or chemical processes, based on typical patent classifications (though actual details would specify). Its claims encompass a combination of composition claims, process claims, and potentially, method-specific claims aimed at broad or narrow operational scopes.

The patent’s main novelty likely hinges on a new combination of reactants or a unique procedural step that improves efficacy, stability, or manufacturability. Its claims are structured to defend its inventive core from infringement while establishing a competitive moat in the relevant field.


Analysis of the Claims

Claim Structure and Scope

The claims of the ’914 patent, typically comprising independent and dependent claims, delineate the boundaries of the invention. The independent claims set out the broadest legal scope, while dependent claims add specific limitations or embodiments that refine the invention’s coverage.

Breadth and Innovation

A critical examination reveals whether the claims ambitiously embrace a broad technological landscape or are narrowly tailored to specific embodiments. Excessively broad claims risk being invalidated for lack of novelty or obviousness, particularly if prior art disclosures are abundant. Conversely, overly narrow claims may provide limited commercial protection.

Claim Language and Specificity

The language employed in the claims influences enforceability. Precise terminology reduces ambiguity but may restrict scope. Broad terms such as "comprising," "including," or "consisting of" influence the breadth. For example, a claim stating "a composition comprising component A and component B" can be infringed by compositions with additional components unless explicitly limited.

Novelty and Non-Obviousness

The novelty of the ’914 patent hinges on whether its claims introduce elements not disclosed in prior art. An examination of patent databases and scientific literature reveals the development trajectories and whether similar claims exist. Non-obviousness evaluations consider whether the claimed inventions would have been apparent to skilled persons combining prior art references.


Potential Vulnerabilities and Strengths

Prior Art Challenges

Given the rapid pace of technological development, prior art—comprising existing patents, publications, and public disclosures—may threaten validity if similar compositions or methods are disclosed. The ’914 patent’s strength depends on demonstrating that its claims are distinguishable over such disclosures.

Patent Fence and Freedom to Operate

The landscape surrounding the ’914 patent likely includes a dense network of patents—either overlapping or adjacent—that could serve as either cornerstones or barriers. It’s crucial to evaluate whether the claims intersect with other patents, potentially generating infringement risks or limiting licensing opportunities.

Prosecution History and Amendments

Reviewing the patent prosecution history reveals whether claim amendments narrowed scope over iterations and whether the patent examiner raised substantive rejections based on prior art, inventive step, or clarity issues. This history aids in assessing enforceability and potential for future legal challenges.


The Patent Landscape

Competitive Patent Filings and Portfolio Strategies

The ’914 patent exists within a vibrant patent ecosystem. Industry players, academic institutions, and startups may file related applications, aiming for similar claims or improved embodiments. Notably, the area likely features a portfolio of patents and applications (e.g., USPTO, EPO, PCT filings) that collectively define the technological frontier.

Key Players and Patent Families

Analyzing entities holding patents in similar domains illuminates competitive positioning. If the assignee of the ’914 patent maintains a broad patent family, it can leverage it for licensing or litigation, establishing dominance. Conversely, a fragmented portfolio may suggest strategic workarounds by competitors.

Legal and Market Implications

The ’914 patent’s robustness influences licensing negotiations, potential litigation, and market entry barriers. If the claims are narrow or undermined by prior art, competitors can design around them; if robust, the patent affords substantial strategic leverage.


Critical Evaluation

Strengths

  • Precise claim language that encapsulates a novel combination or process.
  • Demonstrated inventive step over closest prior art, supported by prosecution history.
  • Strategic claim breadth offering a healthy exclusion zone against competitors.

Weaknesses

  • Limited claim scope risking invalidation if prior art predates the filing date.
  • Potential overlaps with existing patents leading to freedom-to-operate concerns.
  • Narrow dependent claims that restrict enforcement or licensing.

Opportunities

  • Expanding the patent portfolio with continuations, divisionals, or method claims aligned with ongoing R&D.
  • Strategic licensing leveraging the patent’s enforceable scope.
  • Utilizing the patent to block competitors or support partnerships in commercialization.

Threats

  • Challengers submitting prior art submissions to invalidate key claims.
  • Patent trolls or non-practicing entities seeking to leverage the patent for licensing.
  • Changes in patent laws affecting claim validity or enforcement, particularly post-AIA.

Conclusion

The ’914 patent’s claims and positioning reflect a calculated effort to secure a meaningful competitive advantage within its technological space. Its enforceability and strategic value depend critically on the specificity of claims, validation against prior art, and the surrounding patent landscape. Businesses should continuously monitor relevant patents and legal developments to safeguard their interests and capitalize on the patent’s value.


Key Takeaways

  • Claim Clarity and Breadth: Precise, well-crafted claims maximize enforceability; overly broad claims risk invalidation.
  • Prior Art Vigilance: Ongoing review of prior art is essential to defend against validity challenges.
  • Portfolio Expansion: Filing continuation applications can broaden protection and adapt to evolving R&D.
  • Competitive Landscape: Mapping related patents informs licensing strategies and mitigate infringement risks.
  • Legal Certainty: Thorough prosecution and strategic patent drafting underpin the patent’s strength in litigation and licensing engagements.

FAQs

1. What are the primary factors that influence the validity of the claims in the ’914 patent?
Claim validity hinges on novelty, non-obviousness, and sufficiently detailed disclosure. Overlap with prior art and ambiguity in claim language can threaten validity.

2. How does the surrounding patent landscape impact this patent’s enforceability?
A dense patent environment increases risks of infringement and invalidation; strategic positioning involves analyzing overlapping claims and potential licensing opportunities.

3. Can the scope of the ’914 patent’s claims be broadened post-grant?
Broadening claims post-grant is limited; inventors often pursue continuation or divisional applications to extend scope or cover new embodiments.

4. What strategies can stakeholders employ to mitigate infringement risks associated with this patent?
Conduct comprehensive freedom-to-operate analyses, consider licensing or designing around specific claims, and monitor patent filings in the domain.

5. How does patent prosecution history influence future enforcement?
Prosecution history clarifies claim scope and amendments, informing enforcement strategies and potential defenses during litigation.


References

[1] United States Patent and Trademark Office, Patent Full-Text and Image Database.
[2] Patent landscape reports, industry filings, and legal analyses relevant to the ’914 patent’s domain.
[3] Legal precedents and patentability guidelines from the U.S. Patent Office and Federal Circuit.

More… ↓

⤷  Start Trial

Details for Patent 10,034,914

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
United Therapeutics Corporation UNITUXIN dinutuximab Injection 125516 March 10, 2015 ⤷  Start Trial 2037-03-16
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.